Studies on the role of calcium and phospholipase C in the morphine withdrawal syndrome.
Pellegrini-Giampietro
D E
DE
Department of Pharmacology, University of Florence, Italy.
Cherici
G
G
Moroni
F
F
D000818:Animals; D002118:Calcium / Q000502:physiology*; D002121:Calcium Channel Blockers / Q000494:pharmacology; D004343:Drug Implants; D009020:Morphine / Q000008:administration & dosage; D009021:Morphine Dependence / Q000503:physiopathology*; D009270:Naloxone / Q000494:pharmacology; D051381:Rats; D013375:Substance Withdrawal Syndrome / Q000503:physiopathology*; D010738:Type C Phospholipases / Q000502:physiology*
D002121:Calcium Channel Blockers; D004343:Drug Implants; D009270:Naloxone; D009020:Morphine; D010738:Type C Phospholipases; D002118:Calcium